The results of our immunohistochemistry evaluation of APL mice liver tissue also show that TX down-regulated MDM2 expression in a dose dependent manner (Fig.5A&B[i-v]), leading to p53 activation in APL mice bone marrow cells. The gene discussed is MDM2; the disease is acute promyelocytic leukemia.